How much is Envisagenics worth in 2026?

Envisagenics has a current valuation of $150.0M based on their Later Stage VC round and secondary market data.

How much funding has Envisagenics raised?

Envisagenics has raised $40.5M in total funding across 0 funding rounds.

Envisagenics

Website

Envisagenics valuation and funding history | Last updated: July 18, 2024

Current Valuation

$150.0M

As of July 18, 2024

Total Funding Raised

$40.5M

Last Round

Later Stage VC

$25.0M

Last Funding

Jul 2024

Funding date

Capital Efficiency

3.71x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Envisagenics is currently valued at $150.0M as of July 18, 2024. The company has raised a total of $40.5M in funding.

Capital Efficiency

With a capital efficiency ratio of 3.71x, Envisagenics has achieved a valuation that is 3.71 times the total capital raised.

Track Envisagenics Valuation Updates

Get notified when Envisagenics raises new funding or valuation changes

Explore More Data

Detailed analysis for Envisagenics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Envisagenics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Envisagenics Worth in 2026?

Envisagenics is a leading private company in the technology sector. Track Envisagenics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Envisagenics Valuation is Determined

Private company valuations like Envisagenics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.